1. Home
  2. JZ vs CLDI Comparison

JZ vs CLDI Comparison

Compare JZ & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JZ
    SELLHOLDBUYas of 6 hours ago
  • CLDI
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • JZ 2011
  • CLDI 2014
  • Country
  • JZ China
  • CLDI United States
  • Employees
  • JZ N/A
  • CLDI N/A
  • Industry
  • JZ Other Consumer Services
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JZ Real Estate
  • CLDI Health Care
  • Exchange
  • JZ Nasdaq
  • CLDI Nasdaq
  • Market Cap
  • JZ 26.7M
  • CLDI 22.3M
  • IPO Year
  • JZ 2022
  • CLDI N/A
  • Fundamental
  • Price
  • JZ $0.87
  • CLDI $0.50
  • Analyst Decision
  • JZ
  • CLDI Strong Buy
  • Analyst Count
  • JZ 0
  • CLDI 2
  • Target Price
  • JZ N/A
  • CLDI $15.00
  • AVG Volume (30 Days)
  • JZ 3.6K
  • CLDI 358.9K
  • Earning Date
  • JZ 01-01-0001
  • CLDI 05-13-2025
  • Dividend Yield
  • JZ N/A
  • CLDI N/A
  • EPS Growth
  • JZ N/A
  • CLDI N/A
  • EPS
  • JZ N/A
  • CLDI N/A
  • Revenue
  • JZ $50,810,288.00
  • CLDI N/A
  • Revenue This Year
  • JZ N/A
  • CLDI N/A
  • Revenue Next Year
  • JZ N/A
  • CLDI N/A
  • P/E Ratio
  • JZ N/A
  • CLDI N/A
  • Revenue Growth
  • JZ N/A
  • CLDI N/A
  • 52 Week Low
  • JZ $0.53
  • CLDI $0.46
  • 52 Week High
  • JZ $2.34
  • CLDI $8.30
  • Technical
  • Relative Strength Index (RSI)
  • JZ 49.38
  • CLDI 28.70
  • Support Level
  • JZ $0.74
  • CLDI $0.53
  • Resistance Level
  • JZ $0.92
  • CLDI $0.79
  • Average True Range (ATR)
  • JZ 0.08
  • CLDI 0.06
  • MACD
  • JZ -0.01
  • CLDI -0.01
  • Stochastic Oscillator
  • JZ 51.88
  • CLDI 3.53

Stock Price Comparison Chart: JZ vs CLDI

JZ
CLDI
2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April02468101214161820JZ VS CLDI

About JZ Jianzhi Education Technology Group Company Limited

Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use